| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
New York, NY, November 5, 2026 – Oscar Health, Inc. (“Oscar Health” or the “Company”) (NYSE: OSCR) announced today its financial results for the third quarter ended September 30, 2026, and updates to its full year 2026 outlook. |
| 16 Sep 2026 |
8-K: Regulation FD Disclosure
As previously announced, Oscar Health, Inc. (the “Company” or “Oscar”) will host its 2026 Investor Day on Wednesday, September 16, 2026, beginning at 9:00 a.m. Eastern Time. At the event, the Company will discuss its strategy and long-te... |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
New York, NY, August 6, 2026 – Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR) announced today its financial results for the second quarter ended June 30, 2026 and updates to its full year 2026 guidance. |
| 09 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On June 4, 2026, Oscar Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 10, 2026 (the “Record Date”), there were 265,530,268 shares of Class A common s... |
| 08 Jun 2026 |
8-K: Regulation FD Disclosure
Oscar Health, Inc. (the “Company”) will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference (the “Conference”) on June 8, 2026 at approximately 11:20 AM ET. At the Conference, the Company plans to... |
| 02 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On May 29, 2026, Oscar Health, Inc. and Oscar Management Corporation (together, the “Company”) and Mario Schlosser entered into an amended and restated employment agreement (the “A&R Employment Agreement”), effective as of June 1, 2026 (... |
| 06 May 2026 |
8-K: Results of Operations and Financial Condition
New York, NY, May 6, 2026 – Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR) announced today its financial results for the first quarter ended March 31, 2026. |
| 21 Apr 2026 |
8-K: Regulation FD Disclosure
NEW YORK – April 21, 2026 – Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced the appointment of independent director Siddhartha Sankaran as Chair of the Board, effective... |
| 02 Mar 2026 |
8-K: Regulation FD Disclosure
Oscar Health, Inc. (the “Company”) will participate in the 2026 Raymond James Institutional Investors Conference (the “Conference”) on March 2, 2026. At the Conference, the Company will reaffirm the full year 2026 guidance that it provid... |
| 10 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
Exhibit 10.1 CREDIT AGREEMENT dated as of February 6, 2026, among OSCAR HEALTH, INC., as Borrower, JPMORGAN CHASE BANK N.A., as Administrative Agent and an L/C Issuer; THE LENDERS AND OTHER L/C ISSUERS PARTY HERETO; and JPMORGAN CHASE BA... |
| 29 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition; Other Events
New York, NY, November 6, 2025 – Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR) announced today its financial results for the third quarter ended September 30, 2025, and reaffirmed its full year 2025 outlook, across all metri... |
| 18 Sep 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
INDENTURE, dated as of September 18, 2025, between Oscar Health, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). |
| 16 Sep 2025 |
8-K: Termination of a Material Definitive Agreement; Other Events
Oscar Health Prices Upsized $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market |
| 15 Sep 2025 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more
Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market |
| 03 Sep 2025 |
8-K: Regulation FD Disclosure
Oscar Health, Inc. (the “Company”) will participate in the 2025 Wells Fargo Healthcare Conference (the “Conference”) on September 3, 2025. At the Conference, the Company will reaffirm the updated full year 2025 guidance that it provided ... |
| 06 Aug 2025 |
8-K: Results of Operations and Financial Condition
New York, NY, August 6, 2025 – Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metr... |
| 22 Jul 2025 |
8-K: Results of Operations and Financial Condition
New York, NY, July 22, 2025 – Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updat... |
| 06 Jun 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On June 4, 2025, Oscar Health, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 10, 2025 (the “Record Date”), there were 218,993,334 shares of Class A common s... |
Loading...